The latest financial statement is for the quarter ending 2026-03-31.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income (loss) | 59,800 | -84,600 | 43,500 | -126,000 |
| Depreciation and amortization | 22,700 | 27,900 | 28,000 | 50,500 |
| Goodwill impairment charge | - | - | - | 183,800 |
| (gain) loss on strategic investment | - | -23,700 | 0 | -2,500 |
| Non-cash operating lease costs | 2,800 | 3,200 | 3,200 | 8,300 |
| Deferred income taxes | 15,500 | -25,600 | 26,000 | -5,100 |
| Disposal/impairment of assets | - | 1,400 | 1,800 | - |
| Restructuring and other (income) charges, net | 8,300 | 11,600 | 9,900 | 34,200 |
| Cto resales | - | 0 | 0 | 0 |
| Lifo charge (liquidation) | 600 | 1,700 | -2,000 | -6,500 |
| Share-based compensation | 4,800 | 4,500 | 5,300 | 8,500 |
| Pension and other postretirement benefit costs | - | 1,200 | - | - |
| Impairment of license agreement | 2,800 | - | - | - |
| Goodwill impairment charge | - | 0 | 183,800 | - |
| (gain) loss on sale of business | 55,600 | - | - | - |
| Cto supply contract termination charges | - | - | 0 | - |
| Impairment, long-lived asset, held-for-use | - | 109,300 | - | - |
| Litigation charges | -16,200 | - | - | - |
| Other non-cash items | -2,600 | -100 | -1,600 | -5,900 |
| Accounts receivable, net | 24,200 | -46,100 | -15,200 | 49,100 |
| Inventories, net | 24,500 | -16,000 | -6,400 | -17,800 |
| Prepaid and other current assets | 2,200 | -1,900 | -1,400 | 2,000 |
| Planned major maintenance outage | - | 3,500 | - | 3,000 |
| Accounts payable | -11,600 | -8,500 | -200 | 6,100 |
| Accrued expenses | 4,400 | -15,100 | 9,200 | -8,200 |
| Accrued payroll and employee benefits | -14,200 | 5,900 | 3,500 | -2,500 |
| Income taxes | 1,300 | -2,500 | -8,400 | 9,700 |
| Restructuring and other cash outflow, net | -8,600 | -10,700 | -12,300 | -23,100 |
| Operating leases | 4,100 | 4,500 | 4,500 | 10,500 |
| Cto resales cash inflow (outflow), net | 0 | 0 | 0 | -6,200 |
| Cto supply contract termination cash outflow | - | - | 0 | - |
| Changes in other operating assets and liabilities, net | -1,200 | -600 | 900 | -6,900 |
| Net cash provided by (used in) operating activities | -2,000 | 97,100 | 129,700 | 104,400 |
| Capital expenditures | 10,300 | 23,600 | 11,900 | 22,200 |
| Sale (purchase) of strategic investments, net | - | 16,400 | - | - |
| Proceeds from sale of business | 93,100 | - | - | - |
| Restricted investment | 24,700 | 13,000 | - | - |
| Purchase of strategic investments | - | - | 21,000 | - |
| Proceeds from disposition of assets | 0 | 0 | - | 3,600 |
| Other investing activities, net | 1,200 | 12,700 | -8,400 | -4,300 |
| Net cash provided by (used in) investing activities | 106,300 | -15,100 | -28,100 | -14,300 |
| Proceeds from revolving credit facility and other borrowings | 713,800 | 81,800 | 51,000 | 158,500 |
| Payments on revolving credit facility and other borrowings | 718,000 | 133,600 | 120,700 | 229,300 |
| Debt issuance costs | 4,000 | 0 | - | - |
| Finance lease obligations, net | -300 | -400 | -300 | -600 |
| Tax payments related to withholdings on vested equity awards | 4,300 | 900 | 200 | 2,600 |
| Proceeds and withholdings from share-based compensation plans, net | 3,300 | 800 | 600 | - |
| Repurchases of common stock under stock repurchase plan | 52,300 | 31,100 | 25,200 | - |
| Net cash provided by (used in) financing activities | -61,800 | -83,400 | -94,800 | -74,000 |
| Increase (decrease) in cash, cash equivalents, and restricted cash | 42,500 | -1,400 | 6,800 | 16,100 |
| Effect of exchange rate changes on cash | 200 | -400 | 500 | 4,400 |
| Change in cash, cash equivalents, and restricted cash | 42,700 | -1,800 | 7,300 | 20,500 |
| Cash, cash equivalents, and restricted cash at beginning of period | 112,600 | 114,400 | 86,600 | - |
| Cash, cash equivalents, and restricted cash at end of period | - | 112,600 | - | - |
| Cash, cash equivalents and restricted cash at end of period | 155,300 | - | 114,400 | - |
Ingevity Corp (NGVT)
Ingevity Corp (NGVT)